Ottawa-area residents invited to participate in multivalent COVID-19 vaccine trial
October 5, 2022 - Healthy adults are invited to participate in a clinical trial at The Ottawa Hospital to test a multivalent coronavirus vaccine candidate developed by VBI Vaccines Inc., a biotechnology company with Ottawa-based research and development facilities. |
Virus versus virus: novel approach shows promise against HIV in lab study
July 12, 2021 - Thanks to the development of effective drugs, HIV has become a chronic, treatable condition for most people. But it still isn’t curable, and that isn’t good enough for Dr. Jonathan Angel and his colleagues. |
The Ottawa Hospital contributes to ‘a beautiful evolution’ in HIV research and care
December 4, 2020 - In honour of World AIDS day, we take a look back at how The Ottawa Hospital played a major role in caring for patients with HIV, how it continues to lead life-saving research, and how it is transforming how HIV is managed today. |
The Ottawa Hospital awarded six CIHR grants worth $2.6 million
September 7, 2020 - Could a common diabetes drug help prevent ovarian cancer? Can a tailored screening program help prevent eye disease in immigrants? Is sepsis different in females versus males, and if so, can this help us develop better treatments? These are just ... |
The next frontier in HIV research: Ottawa scientists to play key role in new $17M prevention and cure studies
August 14, 2019 - Despite great strides in HIV research, over 75,000 Canadians are living with HIV and approximately seven more contract it every day. And this incurable virus continues to take a huge toll around the world. The Government of Canada recently ... |
Using viruses to fight viruses: new approach eliminates “dormant” HIV-infected cells
December 18, 2017 - While Ottawa researchers are known for their work on cancer-fighting viruses, one team is applying these viruses to a new target: HIV.
Researchers at The Ottawa Hospital and the University of Ottawa have discovered that the Maraba virus, or MG1, c |
HIV kept at bay with single injection every 8 weeks
August 17, 2017 - Over the last two decades, HIV has been transformed from a death sentence into a chronic, treatable disease, requiring just a single pill a day to keep the virus at bay for most people. A study co-authored by Dr. Jonathan Angel has now paved the wa |
Ottawa researchers to play major role in $8.7M research project aimed at curing HIV
November 28, 2013 - Researchers from The Ottawa Hospital, CHEO and the University of Ottawa (uOttawa) will play a major role in a new research project that aims to find a cure for HIV and contribute to the global effort to put an end to AIDS. The project was awarded $8. |
Ottawa research could reduce use of unnecessary medications in people with HIV
December 16, 2011 - New research led by Dr. Jonathan Angel could spare many people with HIV from having to take unnecessary antibiotics associated with major side effects. A systematic review by Dr. Angel and his colleagues showed that when viral levels are suppressed, |
